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LysosomesThe Na+/K+-ATPase interacts with the non-selective cation channels TRPC6 but the functional consequences of
this association are unknown. Experiments performed with HEK cells over-expressing TRPC6 channels showed
that inhibiting the activity of the Na+/K+-ATPase with ouabain reduced the amount of TRPC6 proteins and de-
pressed Ca2+ entry through TRPC6. This effect, not mimicked by membrane depolarization with KCl, was
abolished by sucrose and baﬁlomycin-A, and was partially sensitive to the intracellular Ca2+ chelator BAPTA/
AM. Biotinylation and subcellular fractionation experiments showed that ouabain caused amultifaceted redistri-
bution of TRPC6 to the plasma membrane and to an endo/lysosomal compartment where they were degraded.
The amyloid beta peptide Aβ1–40, another inhibitor of the Na+/K+-ATPase, but not the shorter peptide Aβ1–16, re-
duced TRPC6 protein levels and depressed TRPC6-mediated responses. In cortical neurons from embryonic mice,
ouabain, veratridine (an opener of voltage-gated Na+ channel), and Aβ1–40 reduced TRPC6-mediated Ca2+ re-
sponses whereas Aβ1–16 was ineffective. Furthermore, when Aβ1–40 was co-added together with zinc acetate it
could no longer control TRPC6 activity. Altogether, this work shows the existence of a functional coupling be-
tween the Na+/K+-ATPase and TRPC6. It also suggests that the abundance, distribution and activity of TRPC6
can be regulated by cardiotonic steroids like ouabain and the naturally occurring peptide Aβ1–40 which under-
lines the pathophysiological signiﬁcance of these processes.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
One key function of biological membranes is to maintain an uneven
distribution of ions such as Na+, K+, Ca2+, and Cl−. Among the various
proteins participating in the ionic homeostasis, the Na+/K+-ATPase is
an essential actor. Its basic function is to maintain the cytosolic concen-
trations of Na+ and K+ by pumping out Na+ and pumping K+ into the
cytosol [1,2]. Various conditions and actors like Na+ ions, cytoskeleton
proteins, neurotransmitters, peptides, protein kinases, and clinically rel-
evant drugs such as ouabain-like cardiotonic steroids have been shown
to inﬂuence the activity of the Na+/K+-ATPase [1,2]. The pathophysio-
logical relevance of this regulation for neuronal function is illustrated
by the fact that amyloid-beta (Aβ) peptides, which are described as
playing a central role in Alzheimer's disease, inhibit the activity of thisF-38000 Grenoble, France.pump [3–5]. This impairs neuronal Na+ and Ca2+ homeostasis and
increases the vulnerability of cells to apoptotic insults [6].
The Na+/K+-ATPase interacts with several types of channels and
transporters of the plasma membrane: AMPA channels (a subtype of
ionotropic glutamate receptors), GlyT2 (a glycine transporter), GLAST
(a glutamate transporter), Nax (a neuronal Na+-sensing channel),
AQP4 (the water channel aquaporin 4), and TRPC6 (a non-selective cat-
ion channel) [7,8]. The functional implications of these protein–protein
interactions are just beginning to be understood. For instance, ouabain,
a speciﬁc inhibitor of the Na+/K+-ATPase [1,9], induces the endocytosis
and degradation of AMPA receptors and GlyT2 [10,11]. Like these 2 lat-
ter proteins, TRPC6 transports Na+ ions through the plasmamembrane
[12,13], and associates with the Na+/K+-ATPase [7,8]. However, the
functional consequences of the interaction between TRPC6 and the
Na+/K+-ATPase have not been addressed. The present report was un-
dertaken to better understand the role played by the Na+/K+-ATPase
on TRPC6 activity. This issue is of importance because TRPC6 is found
in many tissues and organs, including in the brain where it plays key
roles in neuronal survival, dendritic growth and synaptogenesis [14].
2958 S. Chauvet et al. / Biochimica et Biophysica Acta 1853 (2015) 2957–29652. Materials and methods
2.1. Cell cultures and transfection
HEK-293 and HEK-293 cells stably over-expressing TRPC6 (HEK-
TRPC6) were maintained in culture according to experimental condi-
tions described elsewhere [15,16]. HEK cells stably over-expressing
TRPM4 channelswere cultured as described previously [17]. The culture
medium of all cell lines was without penicillin/streptomycin. Primary
cultures of cortical neurons were prepared from embryonic (E13) wild
type C57BL6 mice according to [18]. The procedures used were ap-
proved by the ethical committee of the CEA's Life Sciences Division
(CETEA).
2.2. Protein extraction and immunoblotting analysis
Cells were rinsed twice with a phosphate-buffer saline and lysed on
ice in 50–100 μl of extraction buffer (10 mM HEPES, pH 7.5, 3 mM
MgCl2, 40 mM KCl, 2,5% Glycerol, 1% triton X-100 and 1:300 protease
inhibitor cocktail, Sigma) for 30 min. The lysate was then centrifuged
at 15,000 rpm for 30min at 4 °C. The supernatant was collected and fro-
zen at−80 °C for subsequent use. Protein concentration wasmeasured
using the Bradford assay. Thirty μg of each extract was boiled with 2×
Laemmli buffer, separated by SDS-PAGE and then electrotransferred
(Bio-Rad system) onto nitro-cellulose membranes (Bio-Rad). They
were blocked with milk 5% in PBS –0.1% Tween overnight. They were
then probed with primary antibodies raised against TRPC6 (Alomone
labs), α1Na+/K+-ATPase subunit, or actin (Sigma). This was followed
by incubation with appropriate horse-radish peroxidase-conjugated
secondary antibodies (Bethyl). Bands were detected by chemilumines-
cence (ECL, Pierce) using a Fusion Fx7 apparatus (Vilbert Lourmat).
Quantiﬁcation of protein expression was made with ImageJ software:
for a given protein, its expressionwas normalized to the level of expres-
sion of actin. The results presented were the results of at least three
measurements from three independent cultures for each condition.
2.3. Preparation of the amyloid-beta peptides aβ1–40 and aβ1–16
Aβ1–16 (sequence DAEFRHDSGYEVHHQK) and Aβ1–40 peptides
(sequence DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV)
were bought from GeneCust (Dudelange, Luxembourg). They were
solubilized in 30 mM NaOH. Peptide concentration was then deter-
mined by UV–visible absorption of Tyr10 considered as free tyrosinate
((λ293–λ360) = 2130 M−1cm−1) [19].
2.4. Subcellular fractionation
First, HEK-293 cells stably expressing TRPC6 were subjected to a
slightly modiﬁed version of de Duve's subcellular fractionation scheme,
as described [20]. The membrane organelle fractions prepared from the
post-nuclear supernatant (i.e. M, Heavy mitochondrial; L, Light mito-
chondrial; and P, microsomal) were then pooled and fractionated
in an 18% self-forming Percoll™ (Pharmacia) density gradient, as de-
scribed [20]. Seven sections were collected from the top of the gradient,
and the distribution of a lysosomalmarker (β-galactosidase) and a plas-
ma membrane marker (alkaline phosphodiesterase) was determined
by enzyme assays [20,21]. The distribution of TRPC6 was assessed by
Western blotting.
2.5. Cell surface biotinylation assay
The cell surface level of TRPC6 was measured using sulfo-NHS-SS-
biotin [sulfosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate]
(Pierce) to label proteins located at the plasmamembrane, as described
previously [22], except that a concentration of 2 mg/mL of biotin
substrate was used and that the cells were lysed in PBS-Triton 1%containing protease inhibitors (Complete Mini Tablets, Roche) [22].
Detection of GAPDH by Western blotting (Sigma antibody) was used
to control the impermeability of the cells to the biotin reagent, and to
normalize signal intensities.
2.6. Live-cell Ca2+ imaging experiments
The ﬂuorescent indicator Fluo-4 was used to monitor cytosolic Ca2+
according to [15,23]. Brieﬂy, the culturemediumwas removed and cells
were rinsed twice with a saline containing: (in mM) 140 NaCl, 5 KCl, 2
CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, pH 7.4 (NaOH). Cells were incu-
batedwith theﬂuorescent probe for 20min at room temperature before
beingwashed twicewith a ﬂuorescent probe-free solution. Fluo-4-load-
ed cells were kept in the dark at room temperature for 10 min before
being placed on the stage of an Axio Observer A1 microscope (Carl
Zeiss, France) equipped with a Fluar 40× oil immersion objective lens
(1.3 NA) (Carl Zeiss, France). The experimental setup and the recording
conditions were as described [15,23].
2.7. Statistics
Throughout the text, data are presented as means ± s.e.m., or ±SD
(Figs. 4B and 6E). The software SigmaStat (version 3.5, Systat Software)
was used to determine the statistical signiﬁcance of the difference be-
tween groups.
2.8. Materials
Fluo-4/AM as well as tissue culture media were from Molecular
Probes (Invitrogen, France). Hyperforinwas a kind gift fromDr.Willmar
Schwabe GmbH & Co (Karlsruhe, Germany). Unless otherwise indicat-
ed, all the other reagents were from Sigma-Aldrich (France).
3. Results
Throughout this study, the activity of the Na+/K+-ATPase was
inhibited by the glycoside ouabain [1] used at 25 μM, a concentration
2 times smaller than used previously on cultured cortical neurons, cul-
tured brain and spinal cord neurons [10,11], and having no effect on
cell viability [11]. To assess the effect of the ouabain-mediated inhibition
of the Na+/K+-ATPase on TRPC6, HEK cells stably over-expressing
TRPC6 channels (HEK-TRPC6) [15,16] were maintained for varying du-
rations at 37 °C in a culturemedium supplemented with ouabain before
being rinsed twice and collected. Total proteins were extracted and the
amount of TRPC6 proteins was analyzed by Western blotting. As illus-
trated in Fig. 1A, cells exposed to the Na+/K+-ATPase inhibitor ouabain
showed decreased protein levels of TRPC6. This effect developed in a
time-dependent manner (Fig. 1B). For instance, the amount of TRPC6
proteins was reduced by ~30% (n = 4, p b 0.05) and ~55% (n = 8,
p b 0.01) after a 2 h- and a 4 h-ouabain treatment, respectively.
Next, the question of the mechanisms sustaining the reduction of
TRPC6 protein levels was addressed. It is well recognized that the inhi-
bition of theNa+/K+-ATPase depolarizes cells. To test the role of the de-
polarization on the diminution of the abundance of TRPC6 proteins,
HEK-TRPC6 cells were maintained in a culture medium in which
20mMKCl had been added in order to depolarize themembrane. How-
ever, after 4 h in a KCl-rich culture medium, the amount of TRPC6 pro-
teins expressed by HEK-TRPC6 cells was unaffected (Fig. 2). This
ﬁnding is in line with data showing that in cultured cortical neurons
20 mM KCl does not affect the amount of AMPA receptors, which are
also associated with the Na+/K+-ATPase [11].
Ouabain induces the endocytosis and degradation of GlyT2 in
lysosomes [10] whereas the ouabain-dependent degradation of AMPA
receptors involves the proteasome [11]. To investigate the intracellular
pathway responsible for the ouabain-dependent regulation of TRPC6,
experiments were conducted with hypertonic sucrose (which impairs
Fig. 1. Ouabain reduces the amount of TRPC6 protein A. Ouabain (25 μM)was added to the culturemedium of HEK-TRPC6 cells. After 1, 2 or 4 h of treatment (37 °C), ouabainwas washed
away and cell lysateswere collected to probe the total amount of TRPC6 protein byWestern blotting. B. Summary graph showing TRPC6 expression normalized to actin as a function of the
duration of the ouabain treatment. n = 4–9 experiments. Student's t test with * and **, p b 0.05 and p b 0.01, respectively.
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an irreversible proteasome inhibitor, and baﬁlomycin-A (Baf-A), a vesic-
ular ATPase inhibitor that inhibits lysosomal degradation [24–26]. As
illustrated in Fig. 2A–B, both sucrose and Baf-A, but not lactacystein,
prevented the ouabain-dependent reduction of TRPC6 protein levels.
This indicates that lysosomes, rather than proteasomes, are involved in
the ouabain-dependent regulation of TRCP6.
TRPC6 is a non-selective cation channel transporting not only Na+
but also Ca2+ ions [27]. Experiments were undertaken to determine
whether the ouabain-induced reductionof the abundance of TRPC6 pro-
teins developed in response to an entry of Ca2+. This was tested using
the non-speciﬁc Ca2+ channel blocker Gd3+. It was applied at the
concentration of 10 μM which provokes a strong (~70%) blockade
of currents through TRPC6 channels [28]. In the presence of Gd3+,
ouabain was however still able to reduce the amount of TRPC6 proteins
(Fig. 2A–B). In another set of experiments, themembrane-impermeable
Ca2+ chelator EGTA (1 mM) was co-added with ouabain, to further as-
sess the role of external Ca2+ ions. Like Gd3+, EGTA did not prevent the
ouabain-induced reduction of TRPC6 protein levels (Fig. 2). To check for
the contribution of cytosolic Ca2+ changes, cells were pretreated with
50 μM of the membrane-permeable Ca2+ chelator BAPTA/AM. Under
this latter condition, the amount of TRPC6 proteinswas reduced by oua-
bain but not as strongly as without the Ca2+ chelator (Fig. 2A–B), indi-
cating that the ouabain-induced reduction of TRPC6 protein levels was
partially controlled by cytosolic Ca2+ ions.
The data available so far showed that inhibiting the activity of the
Na+/K+-ATPase with ouabain inﬂuences the abundance of channels
and transporters (AMPA receptors, GlyT2, TRPC6) having the shared
property to transport Na+ ions. For TRPC6, this process seemed to de-
velop without the need of an inﬂux of Ca2+ ions. To further document
this hypothesis, experiments were conducted on TRPM4. This protein
was chosen because it forms channels permeant to Na+ but not to
Ca2+ ions [17]. When HEK cells over-expressing TRPM4 (HEK-TRPM4)
were exposed to ouabain, this reduced the protein level of TRPM4 by
~60% when compared to HEK-TRPM4 untreated to ouabain (n = 5,
p b 0.001) (Fig. 2C). Since TRPM4 are Na+-conducting channels, it is
not an inﬂux of Ca2+ ions that was controlling the ouabain-dependent
degradation of TRPM4. This latter observation further suggests that
the Na+/K+-ATPase plays a role in the control of the cellular abundance
of proteins transporting Na+ ions.
TRPC6 is a glycosylated plasmamembrane protein [16] associated to
cholesterol-rich micro-domains located underneath the plasma mem-
brane [29] but it has also been found intracellularly [30,31]. In the
following experiments, the distribution of TRPC6 was investigated in
fractions of a self-forming Percoll™ density gradient loaded with a sub-
cellular fraction containing the membrane bound structures of a post-nuclear supernatant. In this type of discontinuous gradient, the plasma
membrane (identiﬁed by the marker enzyme alkaline phosphodiester-
ase, Fig. 3A) remained in the low density region (fractions 2–3), where-
as lysosomes were recovered in the densest fraction (fraction 7) of the
gradient (as indicated by the detection of lysosomal β-galactosidase,
Fig. 3A). In non-treated cells (control cells), the detection of TRPC6 by
Western blotting highlighted the presence of this protein in the low
density region, mainly in fraction 2 (Fig. 3A). Of note, low amounts
of a lower molecular mass (MM) form of TRPC6 were also detected in
this fraction. Newly synthesized glycoproteins ﬁrst acquire high-
mannose-type oligosaccharidic chains in the endoplasmic reticulum
(ER). These chains can be further processed into complex-type glycans
upon passage through the Golgi apparatus. Treatment of TRPC6 with
PNGaseF, which removes all types of N-glycans, revealed that both
high MM (HMM) and low MM (LMM) TRPC6 forms are N-glycosylated
(Fig. 3E). However, incubation with endoglycosidase H (endo H), which
selectively removes high-mannose structures but not complex-type
structures, highlighted that LMM TRPC6 only bears high-mannose gly-
cans, which would be in accordance with its presence in the ER. By con-
trast, we found that HMM TRPC6 forms bear complex structures (endo
H-resistant), indicating that they have exited the ER and traveled through
the Golgi apparatus.
When HEK-TRPC6 cells were exposed to ouabain, a small amount of
TRPC6 proteins was detected in the lysosomes-containing fraction 7
(Fig. 3B). This re-localization only concerned HMM-TRPC6. Interesting-
ly, the amount of TRPC6 in the fraction 7 (containing the bulk of lyso-
somes) was increased 2–3 fold after exposure of cells to ouabain +
protease inhibitors (leupeptin and pepstatin A), compared to non-
treated cells and leupeptin/pepstatin A-treated cells (Fig. 3A, C, D).
This indicated that ouabain induced the redistribution of TRPC6 from a
post-Golgi compartment to lysosomes, where it was rapidly degraded.
When cells were treated with the protease inhibitors (but in the
absence of ouabain) this did not affect the distribution of TRPC6
(Fig. 3C). To further investigate the plasmamembrane and intracellular
localization of TRPC6 and to better understand the effect of ouabain, cell
surface biotinylation experiments were done (Fig. 4). Under control
conditions (cells not treated with ouabain), ~20% of the total amount
of TRPC6 seemed located at the plasmamembrane (i.e. accessible to bi-
otinylation), suggesting that themajority (~80%) of the TRPC6 protein is
located intracellularly (Fig. 4A). This observation is in line with a previ-
ous study showing that only a small fraction of TRPC6 resides at the
plasmamembrane [29]. Of note, both HMM- and LMM-TRPC6were de-
tected in the non-biotinylated fraction (NB, intracellular fraction),
whereas only HMM-TRPC6 forms were detected in the biotinylated
fraction (B, plasma membrane fraction), indicating that a fraction of
TRPC6 proteins traveled through the Golgi and reached the cell surface.
Fig. 2.Ouabain reduces the amount of TRPC6protein via amechanism sensitive to sucrose,
Baf-A and BAPTA/AMA.HEK-TRPC6 cells were treatedwith 25 μMouabain for 4 h at 37 °C.
The ouabain-containingmediumwas removed, cellswere rinsed twicewith PBS and lysed
before extracting the proteins. In some experiments the ouabain-containingmedium also
contained 0.45 M sucrose, 10 μM GdCl3, 1 mM EGTA, 50 μM BAPTA/AM, 5 μM lactacystin,
or 0.25 μM Baf-A. In each instance, GdCl3, EGTA, BAPTA/AM, lactacystin, or Baf-A was
added to the culture medium 10–15 min before ouabain and remained present during
the application of ouabain. In a set of experiments, the culturemediumwas supplemented
with 20mMKCl (andno ouabain added). B. TRPC6 expression is expressedwith respect to
untreated HEK-TRPC6 cells (control HEK-TRPC6 cells). n = 4–14 experiments. Student's t
test with *p b 0.01 vs Control and †p b 0.01 vs ouabain-treated cells. C. The same experi-
ments as illustrated in Fig. 1A were repeated on HEK cells stably over-expressing TRPM4
channels and treatedwith 25 μMouabain for 2 h. Theﬁgure shows representativeWestern
blots of untreated (control) and ouabain-treated HEK-TRPM4 cells. Experiments conduct-
ed in triplicate.
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duced by ouabain treatment (Fig. 1) was reﬂected by a decrease of the
amount of intracellular forms of TRPC6, affecting mainly HMM-TRPC6
that was reduced by 51.4 + / − 7.6% (p b 0.05) when compared to
non-treated conditions. For the other form (the intracellular LMM-
TRPC6), the decrease observedwas however statistically not signiﬁcant.
On the other hand, the ouabain treatment augmented the amount of
HMM-TRPC6 detected in the biotinylated/cell surface fraction to
167.5 + /− 80.4% (p b 0.05) of control level (Fig. 4B). Combined with
the results of our fractionation experiments, these ﬁndings suggest
that the inhibition of the Na+/K+-ATPase induces the relocalisation
of intracellularHMM-TRPC6 forms to the plasmamembrane, and the ly-
sosomes where they are degraded, thereby resulting in a decrease of
total TRPC6 levels. Interestingly, in HeLa cells TRPC6was found intracel-
lularly and to recycle from the trans-Golgi network and recycling late
endosomes to the cell surface [31].In order to understand the functional consequence of the degrada-
tion/delocalization of TRPC6 proteins in response to the inhibition of
the Na+/K+-ATPase, live-cell Ca2+ imaging experimentswere conduct-
ed on HEK-TRPC6 cells loaded with the ﬂuorescent Ca2+ dye Fluo-4.
SAG (1-stearoyl-2-arachidonyl-sn-glycerol), an analog of the TRPC6
channel activator diacylglycerol (DAG) [32] was used to promote the
entry of Ca2+ through TRPC6 (Fig. 5A). Incubating HEK-TRPC6 cells
with ouabain for varying durations reduced the peak amplitude of
the SAG-induced Ca2+ responses when compared to control (ouabain-
untreated) cells. For instance, these Fluo-4 signals were reduced by
~30% (n = 4, p b 0.05) and 70% (n = 9, p b 0.01) after N30 min and
3-h of treatment, respectively (Fig. 5B).
The Na+/K+-ATPase is subject to regulation [2,33,34] and its activity
can be inhibited not only by amyloid beta-peptides like Aβ1–40 but also
Aβ1–42 and Aβ25–35 [3–5]. It is thus important to determine whether
such peptides having ouabain-like properties could inﬂuence the abun-
dance and activity of TRPC6. In the following experiments, HEK-TRPC6
cells were incubated with the naturally occurring peptide Aβ1–40 or
with a truncated peptide (Aβ1–16). In contrast to Aβ1–16, the full length
peptide Aβ1–40 slightly diminished the amount of TRPC6 proteins by
~15% (n = 4, p b 0.05) (Fig. 6A). To test whether Aβ1–40 exhibited the
same effect as ouabain on the trafﬁcking and lysosomal degradation of
TRPC6, cells treated with Aβ1–40 for 4 h were fractionated in a self-
forming Percoll density gradient (as described in Fig. 3A). Contrary to
ouabain, no re-direction of TRPC6 to lysosomes could be detected in
the presence of Aβ1–40 (Fig. 6B–C). But, similar to ouabain, biotinylation
experiments revealed that the cell surface abundance of TRPC6was aug-
mented by N50% p b 0.05) (Fig. 6D–E). It is interesting to note that, like
ouabain, Aβ1–40 had the tendency to reduce the amount of intracellular
HMM TRPC6. Next, the consequence of the treatment with Aβ1–40
(and Aβ1–16) on the activity of TRPC6 was characterized. As above,
HEK-TRPC6 cells were incubated with 1 μM Aβ1–40 or 1 μM Aβ1–16.
Aβ1–40 but not Aβ1–16 reduced the peak amplitude of SAG-triggered
Ca2+ signals (Fig. 6F).
The effect of ouabain on native TRPC6 channels was investigated. To
this aim, primary cultures of cortical neurons from embryonic mice
were used. Originally cloned from themurine brain [16], TRPC6 is abun-
dantly present in this organ [35–38] where its expression has been de-
tected in neurons and astrocytes [39,40]. Its activity was controlled by
hyperforin, a potent TRPC6 channel activator [41] that, in these cells,
elicits more robust cytosolic Ca2+ signals than SAG. Pretreating cortical
neurons with ouabain depressed the hyperforin-activated Ca2+ re-
sponses (Fig. 7A,C). In contrast to HEK cells, neurons express voltage-
gated Na+ channels. This property allowed us to assess the contribution
of Na+ ions in the regulation of TRPC6. To this aim, cortical neurons
were exposed to veratridine, an alkaloid causing the opening of
voltage-gated Na+ channels and thus promoting the entry of Na+ ions
[42]. If Na+ ions are controlling the ouabain-dependent regulation of
TRPC6 channels, it was speculated that veratridine could also inﬂuence
TRPC6 activity. Veratridine (50 μM for 2 h-treatment) potently reduced
the peak amplitude of the hyperforin-activated Ca2+ responses by ~20–
30% (n=6, p b 0.01) (Fig. 7A,C). It is worthmentioning that veratridine
triggers the degradation of AMPA receptors [11]. This reinforces the idea
that intracellular changes in Na+ ions constitute a key cellular event
controlling the abundance of TRPC6. In the last series of experiments,
the effects of Aβ1–40 and Aβ1–16 on the neuronal hyperforin-activated
Ca2+ responses were analyzed (Fig. 7B–C). Like in HEK-TRPC6 cells,
Aβ1–40 but not Aβ1–16 reduced the peak amplitude of the Ca2+ re-
sponses by ~25% (n = 7, p b 0.01) (Fig. 7C). Zinc (Zn) is an essential
metal present at high concentration in cerebral structures like the cor-
tex and hippocampus. It has been described to be released synaptically
during the electrical activity of neurons and it displays, among other
features, the intriguing property to bind Aβ peptides [43,44]. When
co-added with Aβ1–40, zinc acetate (5 μM) fully prevented the Aβ1–40-
dependent depression of hyperforin-activated Ca2+ responses
(Fig. 7B–C). This latter result indicates that the Aβ1–40-dependent
Fig. 3.Ouabain induces a cellular redistribution of TRPC6 and its degradation A subcellular fraction enriched inmembrane-bound cytoplasmic organelles was prepared from control HEK-
TRPC6 cells (A), HEK-TRPC6 cells incubated with ouabain (B), Leupeptin (Leu)/Pepstatin A (Pepst A) (C), or ouabain + Leu/PepstA (D), and loaded on a self-forming Percoll density gra-
dient. After centrifugation, 7 fractions were collected. A-D show the refractive indexes measured in each fraction (indicative of their density), as well as the distribution of plasma mem-
brane and lysosomalmarker enzymes, alkaline phosphodiesterase and β-galactosidase, respectively. The distribution of TRPC6 was analyzed byWestern blotting. Note than only 1/8th of
fractions 2 and 3were loaded on gel compared to the other fractions. E.HEK-TRPC6 cell lysates were treatedwith endoglycosidase H, which speciﬁcally removes high-mannose-type gly-
cans from glycoproteins, or PNGase F, which removes all types of N-glycans. Note that endoglycosidase H treatment only impacted the migration of low molecular mass (LMM) TRPC6
forms, while having no impact on the migration of high molecular mass (HMM) TRPC6 forms. After incubation with PNGase F, both TRPC6 forms exhibited the same molecular mass.
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Zn2+ ions.
4. Discussion
TRPC6 is a non-selective cation channel playing important roles in
calcium signaling in various tissues and cell types [45]. For instance,
TRPC6-dependent Ca2+ rises are involved in cell growth, differentiation,
or neuronal survival [14,45]. Biotinylation and subcellular fractionation
experiments as well as the use of the glucosidases endoglycosidase H
and PNGase F reveal the presence of several TRPC6 forms (LMM and
HMM) inHEK cellswith distinct glycosylation patterns and distinct sub-
cellular distributions. Part of the population of HMM-TRPC6 forms, i.e.
bearing complex-type oligosaccharides, localizes at the cell surface of
HEK cells whereas LMM-TRPC6 forms (bearing high-mannose glycans)
together with a pool of HMM-TRPC6 are located intracellularly. Underour experimental conditions TRPC6 proteins over-expressed in HEK
cells are predominantly located intracellularly, a ﬁnding which is in
agreement with previous data [16,29].
A key feature of TRPC6 is its ability to translocate froman internal pool
to the cell surface [29]. This exocytotic insertion can be triggered bymus-
carinic agonists [29], diacylglycerol analogs, lysophosphatidylcholine
[46], or reactive oxygen species [47,48]. We now provide experimental
evidence for the existence of a translocation of TRPC6 under the control
of the Na+/K+-ATPase which forms macromolecular complexes with
this channel [7,8]. Some molecular actors controlling the intracellular
trafﬁcking and insertion of TRPC6 into the plasma membrane have
been identiﬁed like the GTPases Rab9 and Rab11 [31]. In addition, the
phosphorylation of TRPC6 at Y284 seems to permit its interaction with
PLC-γ1 and its trafﬁcking to the plasmamembrane [49]. Hence, the phos-
phatase PTEN and Snapin seem to function as scaffold proteins regulating
the cell surface insertion of TRPC6 [50,51]. Of note, clathrin and dynamin
Fig. 4. Ouabain induces the targeting of TRPC6 to the plasma membrane A. The plasma
membrane and intracellular localization of TRPC6 was assessed after ouabain treatment
(2 h) using a cell surface biotinylation assay. 7.5% of the cell surface/biotinylated
(B) fraction was loaded side by sidewith 10% of the intracellular/non biotinylated fraction
(NB). GAPDH was used as a control of cell impermeability to the biotin reagent. One
representative experiment is shown (n = 5). B. The graph shows the amount of high
and low molecular mass (HMM and LMM, respectively) forms of TRPC6 detected in cell
surface and intracellular fractions of ouabain-treated cells, relative to their respective
counterparts in non-treated cells (set to 100%) (n = 5, Student's t-test,*p b 0.05).
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endocytic pathway [8]. More recently SNF8, a component of the ESCRT-
II trafﬁcking complex involved in the degradation of membrane protein,
was proposed as a potential TRPC6-binding partner [52]. Although the
intracellular trafﬁcking and the cell surface insertion of TRPC6 are now
better characterized from a molecular point of view, little is known
about the mechanisms controlling these processes.
The data shown in the present report indicate that the Na+/K+-
ATPase is an important regulator of TRPC6 distribution and activity.Fig. 5.Ouabain reduces TRPC6-mediated Ca2+ responses A. Examples of Fluo-4 recordings (F/F0
ment. SAG was added when indicated by the arrow (and remained present during the entire r
of 0.2 Hz. Panel B shows normalized SAG-dependent Fluo-4 responses under control conditi
Student's t test with * and **, p b 0.05 and p b 0.01, respectively.Inhibition of the pump with ouabain diminishes the total amount of
TRPC6 proteins. The ouabain-dependent reduction of TRPC6 protein
levels does not seem to require an inﬂux of Ca2+ since it is insensitive
to the non-speciﬁc channel blocker Gd3+ and to the extracellular chela-
tor EGTA. It is however sensitive to the intracellular Ca2+ chelator
BAPTA/AM, suggesting that cytosolic changes in Ca2+ are playing a
role in the ouabain-dependent degradation of TRPC6. This latter process
is prevented by Baf-A (acting on lysosomes) and sucrose (affecting
clathrin-dependent endocytosis and endosomal transport), indicating
that the endo/lysosomal system may play a role in the degradation of
TRPC6. In accordancewith this hypothesis, the biotinylation and subcel-
lular fractionation experiments show that ouabain changes the intracel-
lular distribution of TRPC6 and promotes the lysosomal degradation of
HMM-TRPC6. Of note, in cultured brain and spinal cord neurons, the
glycine transporter GlyT2, another Na+/K+-ATPase-interacting protein,
is also degraded in response to ouabain via a lysosomal pathway [10].
Interestingly, a KCl challenge does not reduce TRPC6 levels, showing
that it is the ouabain-dependent alteration of the cellular ion homeosta-
sis and not themembrane potential itself that is driving the degradation
of TRPC6.
In HEK cells, ouabain not only inﬂuences the number and cellular
distribution of TRPC6 proteins, it also depresses TRPC6-mediated Ca2+
responses. In addition, it reduces the total cellular amount of TRPM4, a
Na+-conducting protein not permeant to Ca2+ ions. In cortical neurons
ouabain depresses hyperforin-activated Ca2+ responses. However, it
does not impair the entry of Ca2+ through store-operated Ca2+ chan-
nels (SOCC) (Bouron et al., unpublished data), a class of highly selective
Ca2+ channels not permeant to Na+ ions under physiological condi-
tions. Like ouabain, the Na+-channel opener veratridine depresses
TRPC6-mediated Ca2+ responses, further suggesting that the cytosolic
elevation of Na+ ions is a central key upstream event leading to the
regulation of TRPC6 distribution and activity. Ouabain aswell as veratri-
dine, by elevating the cytosolic concentration of Na+, is able to stimulate
the Na+/Ca2+ exchanger which causes an intracellular Ca2+ rise [53].
Alterations in the homeostasis of Na+ and Ca2+ ions seem to play im-
portant roles in the ouabain-dependent (and veratridine-dependent)
regulation of channels. In addition to perturb the homeostasis of ions
ouabain can activate intracellular signaling cascades because an impor-
tant property of the Na+/K+-ATPase is to function as a transducer re-
ceptor linked to Src kinases [1,54]. As a signaling molecule the Na+/
K+-ATPase could set in motion regulatory pathways inﬂuencing the
properties of unitary TRPC6 channels. For instance, TRPC6 can be regu-
lated by serine or tyrosine phosphorylation leading to changes in
TRPC6 activity [45]. Whether the blockade of the Na+/K+-ATPase) fromHEK-TRPC6 cells stimulatedwith 50 μMSAGwithout and after a 2 h ouabain treat-
ecording). Throughout this study, ﬂuorescent signals (F/F0) were recorded at a frequency
ons and after a ouabain (25 μM) treatment of varying duration. n = 4–10 experiments.
Fig. 6. The amyloid-beta peptide Aβ1–40 (but not Aβ1–16) mimics the effects of ouabain A. The amyloid-beta peptides Aβ1–40 or Aβ1–16 (1 μM)were added to the culture medium of HEK-
TRPC6 cells. After 4 h of treatment (37 °C), peptides were washed away and cell lysates were collected to probe the total amount of TRPC6 proteins byWestern blotting. Non treated HEK-
TRPC6 cells (B) andHEK-TRPC6 cells treated for 4 h at 37 °Cwith the peptide+protease inhibitors (Leu/Pepst A) (C) were fractionated as described in Fig. 3. The refractive indexes of each
fraction of the Percoll density gradient and the distribution of alkaline phosphodiesterase (plasma membrane) and β-galactosidase (lysosomes) were then measured. The distribution of
TRPC6was analyzed byWestern blotting. D. The relative amount of TRPC6 at the cell surface compared to its intracellular formswas estimated by cell surface biotinylation, as described in
Fig. 4. One representative experiment is shown. E. Quantiﬁcations of n = 4 independent experiments (Student's t-test,* p b 0.05). F. Representative ﬂuo-4 recordings (F/F0) from HEK-
TRPC6 cells stimulated with 50 μM SAG without (control) and after a 4 h treatment (37 °C) with 1 μM Aβ1–40 or 1 μM Aβ1–16.
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mains to be ascertained.
Our data as well as previous published data [10,11] suggest that the
Na+/K+-ATPase plays an important role in the regulation of proteins
critical to the transport of Na+ ions across the plasma membrane. The
activity of AMPA receptors, GlyT2, TRPM4 or TRPC6 is associated with
elevated levels of cytosolic Na+ ions. Therefore, molecular actors such
as the Na+/K+-ATPase maintaining the cytosolic concentrations ofNa+ ions are required to preserve the cellular ion homeostasis. Altering
the activity of the pump impairs the maintenance of ionic gradients
which may lead to cell dysfunctions. It is proposed that the redistribu-
tion and degradation of Na+-conducting proteins such as AMPA recep-
tors, GlyT2, TRPM4 and TRPC6 observed in response to the inhibition of
the Na+/K+-ATPase is an important protective feedback mechanism
preventing a cellular Na+-overload and associated disturbances in
cellular ions homeostasis.
Fig. 7. Ouabain, veratridine, an opener of voltage-gated Na+ channel, and Aβ1–40 (but
not Aβ1–16) depress TRPC6 responses in cortical neurons A. Representative Fluo-4 signals
(F/F0) recorded in response to the external application of the TRPC6 channel activator
hyperforin (10 μM, arrow) in control (untreated) cortical neurons and in neurons treated
with ouabain (25 μM)or veratridine (50 μM) for 2 h (37 °C). B. Representative hyperforin-
activated Ca2+ responses under control conditions and after a 4 h treatment with Aβ1–40
(1 μM), Aβ1–40 (1 μM) + Zn acetate (5 μM), or Aβ1–16 (1 μM) are shown. C. Summary
graph showing that ouabain, veratridine and Aβ1–40 (but not Aβ1–16) depress hyperforin-
dependent Ca2+ responses. n = 3–7 experiments. Student's t test with **, p b 0.01.
Fig. 8.Model showing the Na+/K+-ATPase- and Aβ1–40-dependent regulation of TRPC6
channels The scheme illustrates themain results of this study. Two forms of TRPC6 having
a low and a high molecular mass (LMM-TRPC6 and HMM-TRPC6, respectively) were
found in HEK cells. These LMM- and HMM-TRPC6 forms are N-glycosylated but the
LMM-TRPC6 form only bears high-mannose glycans whereas the HMM TRPC6 form
bears complex structures which are endo H-resistant. Note that only the HMM-TRPC6
form is present at the cell surface. Na+/K+-ATPase inhibition with ouabain and Aβ1–40
inﬂuence the cellular redistribution, degradation and activity of TRPC6 channels.
The presence of extracellular Zn ions prevents the Aβ1–40-dependent regulation
of TRPC6. Although this has not been shown here, one cannot exclude the possibility
that some TRPC6 proteins are directly addressed to endo/lysosomal compartments from
the Golgi network.
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ATPase-dependent regulation of TRPC6 channels, experiments were
conducted with the naturally occurring peptide Aβ1–40 known to de-
press Na+/K+-ATPase activity [3–5]. Like ouabain, Aβ1–40 but not the
shorter peptide Aβ1–16, reduces the amount of TRPC6proteins. It also re-
duces the amplitude of the SAG- and hyperforin-mediated Ca2+ re-
sponses. Hence, Aβ1–40 inﬂuences the cellular distribution of TRPC6.
Collectively, these data suggest that low concentrations (μM) of Aβ1–40
may alter TRPC6-dependent cellular responses. Interestingly, Zn pre-
vents theAβ1–40-induced regulation of TRPC6. Since Zn ions are released
in response to nerve stimulation [55], it is suggested that the regulation
of TRPC6 channels exerted by Aβ1–40 may be less pronounced at active
synapses of zincergic neurons [56].
Themain ﬁndings of this report are summarized in Fig. 8. The exper-
imental data presented above provide evidence for the existence of a
functional interaction between the Na+/K+-ATPase and TRPC6 chan-
nels, twomembrane proteins in close proximity and formingmacromo-
lecular complexes [7,8]. By showing that the Na+/K+-ATPase controls
the protein levels of AMPA receptors, GlyT2, TRPM4 and TRPC6, thesepresent and previous studies [10,11] provide new light on the physio-
logical functions exerted by the Na+/K+-ATPase in the control of the
distribution, abundance and activity of cell surface proteins. It is also
shown that Aβ1–40 inﬂuences the cellular distribution, abundance and
activity of TRPC6.
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